These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16651484)

  • 1. Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out.
    Scirica BM; Morrow DA
    Circulation; 2006 May; 113(17):2128-34; discussion 2151. PubMed ID: 16651484
    [No Abstract]   [Full Text] [Related]  

  • 2. Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis.
    Verma S; Devaraj S; Jialal I
    Circulation; 2006 May; 113(17):2135-50; discussion 2150. PubMed ID: 16671184
    [No Abstract]   [Full Text] [Related]  

  • 3. Reverse epidemiology reflects C-reactive protein as a bystander of atherosclerosis in established systemic inflammation models.
    Lin GM; Chu KM; Han CL
    Int J Cardiol; 2011 Feb; 146(3):422-3. PubMed ID: 21093078
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetically elevated C-reactive protein and vascular disease.
    Morita H; Nagai R
    N Engl J Med; 2009 Feb; 360(9):934; author reply 934-5. PubMed ID: 19256031
    [No Abstract]   [Full Text] [Related]  

  • 5. Atherosclerosis, inflammation, and C-reactive protein.
    Harv Mens Health Watch; 2006 Aug; 11(1):6. PubMed ID: 17111477
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
    Nordestgaard BG; Zacho J
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of premature atherosclerosis.
    Kampoli AM; Tousoulis D; Antoniades C; Siasos G; Stefanadis C
    Trends Mol Med; 2009 Jul; 15(7):323-32. PubMed ID: 19577961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of outcome from cardiovascular disease.
    Khuseyinova N; Koenig W
    Curr Opin Crit Care; 2006 Oct; 12(5):412-9. PubMed ID: 16943718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein--does it promote vascular disease?
    Stenvinkel P
    Nephrol Dial Transplant; 2006 Oct; 21(10):2718-20. PubMed ID: 16861733
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnostic value of bilirubin concentrations compared with novel and traditional biomarkers in atherosclerosis with coronary artery disease.
    Yilmaz N; Cicek HK; Celik A; Davutoglu V
    Saudi Med J; 2006 Aug; 27(8):1262-4. PubMed ID: 16883470
    [No Abstract]   [Full Text] [Related]  

  • 11. C-reactive protein and reendothelialization: NO involvement.
    Szmitko PE; Verma S
    Circ Res; 2007 May; 100(10):1405-7. PubMed ID: 17525379
    [No Abstract]   [Full Text] [Related]  

  • 12. Aggregatibacter actinomycetemcomitans induces MMP-9 expression and proatherogenic lipoprotein profile in apoE-deficient mice.
    Tuomainen AM; Jauhiainen M; Kovanen PT; Metso J; Paju S; Pussinen PJ
    Microb Pathog; 2008 Feb; 44(2):111-7. PubMed ID: 17889499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice.
    Ortiz MA; Campana GL; Woods JR; Boguslawski G; Sosa MJ; Walker CL; Labarrere CA
    Exp Biol Med (Maywood); 2009 Jun; 234(6):624-31. PubMed ID: 19359657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of high-sensitivity C-reactive protein and soluble markers of vascular endothelial cell activation in growth hormone-deficient adolescents.
    Lanes R; Marcano H; Villaroel O; Gunczler P; Morillo E; Paoli M; Perez M; Maulino N; Palacios A
    Horm Res; 2008; 70(4):230-5. PubMed ID: 18772596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal C-reactive protein and atherosclerosis.
    Lackner KJ
    Am J Obstet Gynecol; 2009 Aug; 201(2):e14; author reply e14-5. PubMed ID: 19306970
    [No Abstract]   [Full Text] [Related]  

  • 16. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
    Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
    Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia.
    Kovacs A; Tornvall P; Nilsson R; Tegnér J; Hamsten A; Björkegren J
    Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13768-73. PubMed ID: 17702862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [C-reactive protein and risk of ischaemic vascular and cerebrovascular disease--secondary publication].
    Zacho J; Tybjaerg-Hansen A; Jensen JS; Grande P; Sillesen H; Nordestgaard BG
    Ugeskr Laeger; 2009 May; 171(21):1751-5. PubMed ID: 19492468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atherosclerosis--the chronic inflammation of vessel wall].
    Feng ZC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):393-4. PubMed ID: 15932690
    [No Abstract]   [Full Text] [Related]  

  • 20. Inflammatory markers and conventional atherosclerotic risk factors in acute ischemic stroke: comparative study between vascular disease subtypes.
    Suwanwela NC; Chutinet A; Phanthumchinda K
    J Med Assoc Thai; 2006 Dec; 89(12):2021-7. PubMed ID: 17214052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.